In this study, I examined whether a murine T-cell line and three clones that recognize Histoplasma capsulatum antigens in vitro could confer protection in vivo against a challenge of Histoplasma yeasts. C57BL/6 mice were each inoculated with 5 x 104 yeasts intravenously; 1 h later, 5 x 106 or 2 x 107 resting T cells were inoculated intravenously. At week 1 of infection, the T-cell line and all clones failed to reduce the number of H. capsulatum CFU in the spleens of mice compared with numbers in infected controls. Administration of recombinant interleukin 2 or cyclophosphamide to infected mice did not potentiate the functional activity in vivo of either the T-cell line or the clones. In contrast, inoculation with 2 x 107 CD4+ but not CD8+ cells isolated from the spleens of mice immunized with 106 viable yeast cells sharply diminished the number of CFU in the spleens of infected animals. Moreover, splenic CD4+ cells from immune mice transferred a delayed-type hypersensitivity response, whereas the T-cell line and clones did not. Injection of an equal number of cloned T cells and CD8+ splenocytes from immune mice did not transfer resistance to infected mice. Additional studies were undertaken to determine if the ineffectiveness of cloned T cells was associated with a failure to migrate to and survive within spleens of infected mice. B6.PL Thy-la/Cy mice, which are genetically identical to C57BL/6 mice except that T cells of the former bear Thy-1.1 rather than Thy-1.2, were inoculated with Histoplasma yeasts and then injected with immune CD4+ splenocytes or a T-cell clone. At days 1 and 7 of infection, virtually no Thy-1.2+ cells were detected in the spleens of infected mice given cloned T cells. However, the spleens of animals inoculated with immune CD4+ cells contained a small but significant (P < 0.01) proportion of Thy-1.2+ cells at both day 1 and day 7 postinoculation of H. capsulatum. Thus, the failure of T-cell clones to transfer protection against H. capsulatum may be explained by defective trafficking or poor survival in vivo or both.
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An effective host response that successfully limits infection with the pathogenic fungus Histoplasma capsulatum is critically dependent on an interaction between antigenreactive T lymphocytes and macrophages. After stimulation with antigen, T cells secrete a factor(s), closely resembling gamma interferon, that can activate macrophages to inhibit replication of yeast cells (7, 20, 21) . Moreover, protection against a challenge with H. capsulatum can be adoptively transferred to naive recipients by antigen-reactive T cells (15) . Much of the preceding work, however, has been performed with polyclonal populations of T cells.
The ability to isolate and propagate H. capsulatum-reactive murine T-cell lines (TCL) and clones has provided a means of analyzing the role of T cells in antifungal immunity at the single-cell level. It has been reported previously that H. capsulatum-reactive TCL and clones exert multiple immunological functions in vitro. These cells, which are CD3+ (Thy-1.2+) CD4+, proliferate in vitro after stimulation with histoplasmin and confer a delayed-type hypersensitivity (DTH) response when injected with antigen into the footpads of mice. Moreover, the cells release interleukin 2 (IL-2) and a factor(s) that stimulates peritoneal macrophages to limit growth of H. capsulatum yeasts (7) . However, the functional properties of TCL and clones after systemic transfer have not Propagation of TCL and clones and adoptive transfer. The TCL JC1 and clones 1.3G6, 2.3H3, and 2.3E10 were propagated as previously described (7) . For i.v. transfer, resting T cells were harvested and centrifuged over Lympholyte-M (Accurate Chemical and Scientific Corp., Westbury, N.Y.) for 20 min at 400 x g. Lymphocytes were removed, washed, and suspended in Hanks balanced salt solution.
Adoptive transfer of resistance. One hour after i.v. injection of H. capsulatum, each mouse was inoculated i.v. with a 0.5-ml cell suspension containing populations of splenocytes, the TCL JC1, or clones.
Organ culture for H. capsulatum. Spleens from mice infected for 1 week were cultured as described previously (6) .
Adoptive (Fig.  1) . Moreover, CD4+ and CD8+ cells isolated from naive mice did not modify the severity of infection (Fig. 1) 7 . In contrast, a small but significant proportion (P < 0.01) of Thy-1.2+ cells was present in the spleens of infected recipients of splenic CD4+ cells at days 1 and 7. A representative fluorescence profile of splenocytes from mice injected i.v. with 2.3H3 or splenic CD4+ cells is illustrated in Fig. 3 .
In addition, the spleens of B6 Thy-1.1 mice infected for 7 days were cultured for H. capsulatum to verify that CD4+ from C57BL/6 mice could mediate protection in this syngeneic strain. Transfer of 2 x 107 immune CD4+ cells reduced the CFU (P < 0.01) in spleens of B6 Thy-1. however, the in vivo function of H. capsulatum-reactive T cells has been studied with polyclonal populations of these cells (15) . This method has limited the precise analysis of antigen-reactive cells. In the present investigation, I have examined the capacity of homogeneous or monoclonal T cells which recognize Histoplasma antigens to exert antifungal immunity following systemic transfer. The data indicate that both an H. capsulatum-reactive TCL, JC1, and three T-cell clones failed to confer protective immunity to a low inoculum of H. capsulatum yeast cells (5 x 104).
Moreover, these cells did not induce a DTH response after i.v. transfer, although they could mediate local DTH reactivity when transferred with histoplasmin into the footpads of mice (7) .
In contrast to the lack of in vivo function of TCL and cloned T cells after i.v. injection, polyclonal CD4+ T cells obtained from the spleens of immune mice sharply reduced the burden of H. capsulatum in the spleens of infected mice and mediated a DTH response to histoplasmin after adoptive (20, 21 (22) . Furthermore, IL-2 has been used to increase the numbers of cloned T cells in lymphoid organs of mice inoculated with FBL-3, a Friend virus that induces leukemia (16) . Likewise, administration of Cy, which eliminates suppressor T cells (6, 17) , promotes the effectiveness of cloned T cells in vivo (1, 3). In an attempt to improve the function of cloned T cells, mice infected with H. capsulatum were given rIL-2 or Cy in conjunction with cloned T cells. Neither of these reagents, however, potentiated the activity of cloned T cells in vivo.
Many T-cell clones which are active in vitro manifest aberrant migratory patterns and become trapped in the livers and lungs of animals (4, 12) . The abnormal behavior of cloned T cells is associated with the loss of a surface glycoprotein recognized by the monoclonal antibody MEL-14, and this surface molecule appears to be necessary for migration of T cells through the high endothelial vessels in lymph nodes (5, 8) . While the results presented here show that a TCL and cloned T cells failed to reduce the number of H. capsulatum CFU in spleens, they do not address the potential activity of these T cells in other organs in which they become sequestered.
Some investigators have argued that adoptive transfer of antigen-specific cloned T cells may provide a powerful adjunct in the treatment of infectious or oncologic diseases (13, 18) . However, the utility of cloned T cells as adoptive immunotherapy for disseminated infections or malignancies may be severely limited because cells may be unable to migrate to or survive within sites of active disease. It is important to emphasize that the employment of cloned T cells as therapy for certain diseases must await the development of methods that will improve their function in vivo. I thank Caroline Taylor and George Brunner for excellent technical assistance and Angela Birch Smith for assistance with preparation of the manuscript.
